These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1482100)

  • 21. [Cooperation of B- and T-lymphocytes of the human in vitro and in vivo].
    Ambrosius H; Schäffner H
    Z Gesamte Inn Med; 1980 Jan; 35(2):38-42. PubMed ID: 6447413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural killer (NK) cell response to virus infections in mice with severe combined immunodeficiency. The stimulation of NK cells and the NK cell-dependent control of virus infections occur independently of T and B cell function.
    Welsh RM; Brubaker JO; Vargas-Cortes M; O'Donnell CL
    J Exp Med; 1991 May; 173(5):1053-63. PubMed ID: 1850779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Induction of nitric oxide synthesis in mononuclear cells in culture using peritoneal fluid from women with endometriosis, in relation to the percentage of T lymphocytes and NK cells identified in an such environment].
    Henández-Guerrero C; Vadilllo-Ortega F; Beltrán-Montoya J; Farina-Granja M; Avila-Vergara MA; Bustos-López H; Arriaga-Pizano L
    Ginecol Obstet Mex; 2001 Jan; 69():12-23. PubMed ID: 11268729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new mRNA control for lymphocytic activation of NK and T cells.
    Schall RP; Dahl CA
    Mol Immunol; 1991; 28(4-5):559-60. PubMed ID: 2062327
    [No Abstract]   [Full Text] [Related]  

  • 25. Impaired function of innate T lymphocytes and NK cells in the acute phase of ischemic stroke.
    Peterfalvi A; Molnar T; Banati M; Pusch G; Miko E; Bogar L; Pal J; Szereday L; Illes Z
    Cerebrovasc Dis; 2009; 28(5):490-8. PubMed ID: 19752550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [NK cells. I. Their development and biological activity].
    Mikołajczyk-Cichońska A; Gościcka T
    Postepy Hig Med Dosw; 2001; 55(5):655-71. PubMed ID: 11795201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Normal natural killer cell activity in Hodgkin's disease patients in remission.
    Douer D; Shaked N; Ramot B
    Clin Exp Immunol; 1987 Sep; 69(3):660-7. PubMed ID: 3665188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1. Lymphocytes.
    Larosa DF; Orange JS
    J Allergy Clin Immunol; 2008 Feb; 121(2 Suppl):S364-9; quiz S412. PubMed ID: 18241683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preferential proliferation of natural killer cells among peripheral blood mononuclear cells cocultured with B lymphoblastoid cell lines.
    Perussia B; Ramoni C; Anegon I; Cuturi MC; Faust J; Trinchieri G
    Nat Immun Cell Growth Regul; 1987; 6(4):171-88. PubMed ID: 2960890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and gamma/delta TCR+ T lymphocytes. II. Modulation of natural killer cytotoxicity by anti-Kp43 monoclonal antibody.
    Aramburu J; Balboa MA; Izquierdo M; López-Botet M
    J Immunol; 1991 Jul; 147(2):714-21. PubMed ID: 1830071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Limited effect of eicosapentaenoic acid on T-lymphocyte and natural killer cell numbers and functions in healthy young males.
    Miles EA; Banerjee T; Wells SJ; Calder PC
    Nutrition; 2006 May; 22(5):512-9. PubMed ID: 16600816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of natural killer cell activity and T cell proliferation by fresh isolates of human cytomegalovirus.
    Schrier RD; Rice GP; Oldstone MB
    J Infect Dis; 1986 Jun; 153(6):1084-91. PubMed ID: 2422296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural cell-mediated cytotoxicity in guinea pigs: properties and specificity of natural killer cells.
    Altman A; Rapp HJ
    J Immunol; 1978 Dec; 121(6):2244-52. PubMed ID: 722076
    [No Abstract]   [Full Text] [Related]  

  • 34. Natural killer activity against viral targets in cyclosporine-treated renal allograft recipients.
    Cauda R; Citterio F; Tamburrini E; Pozzetto U; Tumbarello M; Castagneto M; Ortona L
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):186-9. PubMed ID: 2834839
    [No Abstract]   [Full Text] [Related]  

  • 35. Phenotype and functional characterization of NK and LAK cells following T-depleted bone marrow transplantation.
    Keever CA; Welte K; Sullivan M; O'Reilly RJ
    Prog Clin Biol Res; 1987; 244():423-32. PubMed ID: 3310004
    [No Abstract]   [Full Text] [Related]  

  • 36. Systemic immunosuppression following a single pharyngeal aspiration of 1,2:5,6-dibenzanthracene in female B6C3F1 mice.
    Smith DC; Smith MJ; White KL
    J Immunotoxicol; 2010; 7(3):219-31. PubMed ID: 20509767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell-mediated tumor-killing effect studied by using bilayer lipid membranes.
    Vassilev PM; Kanazirska MP; Charamella LE; Dimitrov NV; Tien HT
    Cancer Biochem Biophys; 1986 Dec; 9(1):85-95. PubMed ID: 2434213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel 80-kD cell surface structure identifies human circulating lymphocytes with natural killer activity.
    Maïza H; Leca G; Mansur IG; Schiavon V; Boumsell L; Bensussan A
    J Exp Med; 1993 Sep; 178(3):1121-6. PubMed ID: 7688788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
    Ghiringhelli F; Ménard C; Terme M; Flament C; Taieb J; Chaput N; Puig PE; Novault S; Escudier B; Vivier E; Lecesne A; Robert C; Blay JY; Bernard J; Caillat-Zucman S; Freitas A; Tursz T; Wagner-Ballon O; Capron C; Vainchencker W; Martin F; Zitvogel L
    J Exp Med; 2005 Oct; 202(8):1075-85. PubMed ID: 16230475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunomodulating activities on cellular cytotoxicity and the blast transformation of human lymphocytes by 10-[n-(phthalimido)alkyl-2-substituted-10H-phenothiazines and 1-(2-chloroethyl)-3-(2-substituted-10 H-phenothiazin-10-yl)alkyl-1-ureas.
    Petri IB; Szekeres E; Varga E; Berek I; Molnár J; Berek L; Kawase M; Motohashi N
    Anticancer Res; 1996; 16(3A):1247-50. PubMed ID: 8702245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.